Electroacupuncture Improves M2 Microglia Polarization and Glia Anti-Inflammation of Hippocampus in Alzheimer's Disease
Xie et al. · Frontiers in Neuroscience · 2021
Evidence Level
MODERATEOBJECTIVE
To investigate how electroacupuncture affects microglial polarization and inflammation in the hippocampus in an Alzheimer's disease model
WHO
20 male Sprague-Dawley rats with an Alzheimer's disease model induced by Aβ1-42
DURATION
3 weeks of treatment, 6 days per week
POINTS
Baihui (GV-20, 百会) — point located on the top of the head
🔬 Study Design
Control
n=5
no intervention
Saline
n=5
saline injection
Alzheimer's
n=5
Aβ1-42 injection into the hippocampus
Electroacupuncture
n=5
Aβ1-42 + electroacupuncture at GV-20
📊 Results in numbers
Reduction in escape latency in the water maze
Increase in M2 microglia (anti-inflammatory)
Reduction in M1 microglia (proinflammatory)
Decrease in inflammatory cytokines
📊 Outcome Comparison
Escape latency (seconds)
This study showed that electroacupuncture can help reduce inflammation in the brain and improve memory in Alzheimer's disease models. The treatment appears to convert inflammatory cells into protective cells, offering hope for patients with dementia.
Article summary
Plain-language narrative summary
This experimental study investigated the effects of electroacupuncture on the treatment of Alzheimer's disease, focusing specifically on the mechanisms of brain inflammation and microglial activation in the hippocampus. Alzheimer's disease is characterized by progressive loss of memory and cognition, with neuroinflammation playing a crucial role in disease progression. Microglial cells, which act as the brain's immune system, can polarize into two distinct phenotypes: M1 (proinflammatory), which produces toxic substances, and M2 (anti-inflammatory), which promotes neuronal protection and repair. The investigators used 20 male rats divided into four groups: control, saline, Alzheimer's model (induced by injection of Aβ1-42 peptide into the hippocampus), and a group treated with electroacupuncture.
The electroacupuncture protocol consisted of electrical stimulation at the Baihui point (GV-20), located on the top of the head, at a frequency of 20 Hz for 30 minutes, 6 days per week, for 3 weeks. To assess learning and memory, the Morris water maze test was used, in which the animals must find a submerged platform. The results showed significant improvements in the group treated with electroacupuncture. The time to find the platform decreased from 39.15 seconds in the Alzheimer's group to 21.35 seconds in the electroacupuncture group, approaching the values of the control group (18.45 seconds).
Microscopic analyses showed that electroacupuncture reduced excessive activation of both microglia and astrocytes in the hippocampus. More importantly, the treatment promoted polarization of microglia from the M1 (harmful) phenotype to the M2 (protective) phenotype. This effect was accompanied by significant changes in the cytokine profile: a reduction in proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and an increase in anti-inflammatory ones (IL-4 and IL-10). The study also investigated the molecular pathways involved, identifying that electroacupuncture inhibits the NF-κB pathway (associated with inflammation) while activating the Stat6 pathway (associated with anti-inflammation).
These findings suggest that electroacupuncture exerts its neuroprotective effects through modulation of the brain immune system, beneficially rebalancing the inflammatory response. The clinical implications are promising, as they offer evidence that electroacupuncture may be an effective adjunctive therapy for patients with Alzheimer's disease, potentially slowing disease progression through reduction of neuroinflammation. However, it is important to consider the study's limitations, including the small sample size and the use of an animal model, which may not fully reproduce the complexity of human disease.
Strengths
- 1Detailed analysis of molecular and cellular mechanisms
- 2Use of multiple assessment techniques (behavioral, histologic, molecular)
- 3Specific investigation of microglial polarization
- 4Identification of the inflammatory pathways involved
Limitations
- 1Small sample size (5 animals per group)
- 2Animal model may not fully reflect human Alzheimer's disease
- 3Need for clinical studies to validate the findings
- 4Relatively short follow-up period
Expert Commentary
Dr. Marcus Yu Bin Pai
MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
▸ Clinical Relevance
Chronic microglia-mediated neuroinflammation is firmly established as one of the pathophysiologic pillars of Alzheimer's disease, and any intervention capable of modulating that axis deserves serious clinical attention. This work brings relevant mechanistic data for physicians who follow patients with dementia in early or moderate stages, when the window for neuroprotection still exists. The finding that electroacupuncture at GV-20 is able to shift the M1/M2 balance of hippocampal microglia — reducing IL-1β, TNF-α, and IL-6 while raising IL-4 and IL-10 — positions this intervention as a potential adjunct to the current therapeutic arsenal, which still has limited pharmacologic options. Patients under neurologic care who are already taking cholinesterase inhibitors or memantine represent exactly the profile in which a complementary approach with an anti-inflammatory profile may be clinically pertinent.
▸ Notable Findings
The most striking data point is the improvement in escape latency in the Morris water maze — from 39.15 seconds in the Alzheimer's group to 21.35 seconds in the electroacupuncture group, with the control group at 18.45 seconds. In other words, electroacupuncture practically normalized cognitive performance in this model. Mechanistically, the most robust finding is the dual modulation of molecular pathways: inhibition of the NF-κB pathway, classically associated with the inflammatory cascade, with simultaneous activation of the Stat6 pathway, which directs polarization toward the M2 phenotype. This mechanistic specificity is not trivial — it suggests that the observed effect is not nonspecific but mediated by well-characterized brain immune pathways. The simultaneous reduction of three proinflammatory cytokines with elevation of anti-inflammatory markers confirms coherence between the molecular and behavioral outcomes.
▸ From My Experience
In my practice in neurologic rehabilitation, I have been following patients with mild cognitive impairment and early Alzheimer's disease whose families seek adjunctive alternatives. Electroacupuncture at cranial points, particularly GV-20 and GV-24.5, is an approach we have incorporated into the service's protocol precisely because of its safety profile and the neurophysiologic plausibility that studies like this help to ground. I usually observe some stabilization in mood and agitation — outcomes more perceptible to the caregiver — from the fourth or fifth session, with cycles of 10 to 12 sessions before reassessment. We routinely combine this with formal cognitive stimulation and multimodal management of systemic inflammation. The patient profile that seems to respond best, in my clinical observation, is the one with a recent diagnosis, without severe decompensated metabolic comorbidities, and with an active family support network to maintain regularity of sessions.
Full original article
Read the full scientific study
Frontiers in Neuroscience · 2021
DOI: 10.3389/fnins.2021.689629
Access original articleScientific Review
Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories